Thanks for the needle information! It seems like 22 3/4 is the consensus - I'll check what mine is. Sorry to be annoying, but is it possible for you to tell me the exact brand, name, and even serial number? I'd like to look it up and see if my home care company can get it for me.
Tyler Texas, National Jewish, and NIH are the top three NTM places in the country. Some CF centers are extremely knowledgeable as well (e.g., Pittsburgh, where I go, really knows their stuff). I went to National Jewish several years ago and had an excellent experience, but then decided to go to NIH because it's closer to me. I am now a patient of Dr. Olivier, and he's fantastic. At times he directs my treatment (e.g., when I was on the Arikayce clinical trial), and other times he is kind of a consultant for my doctors (which is the case now).
National Jewish has a program where you go out there for several days and get an extremely thorough evaluation. That's what I did shortly after I was diagnosed, and I was so glad that I did. I really learned a lot about the disease and how to try to manage it. I'd definitely recommend looking into it. Perhaps Tyler and NIH have something similar...
Those of us with Abscessus know that there are only a handful of antibiotics we can take. Like others on here, I'm pretty resistant to everything. Right now, I believe my bug is susceptible to Tygacil (haven't tried it yet - I think it's rough on your stomach, and they're kind of saving it for when I REALLY need it), and I'm intermediate to Cefoxitin and Primaxin. But, the susceptibility testing doesn't tell the entire story. When drugs are in your body, they work differently than they do in a petri dish. And, the synergistic effect of multiple drugs isn't shown by the susceptibility testing either. I think the susceptibility testing does tell a lot - it indicates how tough your bug is to treat, and it definitely guides the doctors when they decide what drugs to use. But, I believe treating this thing is part science, part art, and so you do really need a knowledgeable doctor when it comes to Abscessus.
If you haven’t heard of Arikayce, check it out:
http://www.zacks.com/stock/news/137482/Insmed-Soars-on-Arikayces-Breakthrough-Designation
The big news from their Phase 2 trial is that 21 of 68 patients were culture negative at the end of 168 days. For me, I stayed smear positive, however the reduction in mycobacterial density was significant. And physically, I saw a big difference with my cough and my energy level. If I could have stayed on it longer, I can't help but think I would have become culture negative based on how well it was working for me. My guess is we’re still probably a few years away from FDA approval and mass production of this drug, but I think it will eventually help a lot of us!